此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Home Blood Pressure Monitoring Trial

2015年6月5日 更新者:St George's, University of London

Community Based Trial of Home Blood Pressure Monitoring With Nurse Led Support in Patients With Stroke or TIA Recently Discharged From Hospital

Design: Community based randomised trial with follow up after 12 months Participants: 360 patients admitted with stroke or TIA within the past 9 months will be recruited from the wards or outpatients and randomly allocated into two groups. All patients will be visited by the specialist nurse at home at baseline when she will measure their BP and administer a questionnaire. The questionnaire and BP will be repeated at 12 months follow-up by another researcher blind as to whether the patient is in intervention or control group.

Intervention: Intervention patients will be given a validated home BP monitor and support from the specialist nurse. Control patients will continue with usual care (BP monitoring by their practice).

Main outcome measures in both groups after 12months: 1.Change in systolic BP 2.Cost effectiveness: Incremental cost of the intervention to the NHS and incremental cost per quality adjusted life year gained.

Study hypothesis. Home blood pressure monitoring with nurse support wil lead to lower blood pressure after 12 months compared with usual GP care

研究概览

详细说明

High blood pressure in patients with stroke increases the risk of recurrence but management in the community is often inadequate. Home blood pressure monitoring may increase patients' involvement in their care, increase compliance, and reduce the need for patients to attend their GP if blood pressure is adequately controlled. However the value of home monitoring to improve BP control is unclear and there is now a window of opportunity for evaluation before their use becomes widespread in the UK. Furthermore its use in stroke patients presents unique challenges relating to the consequent neurological disability.

研究类型

介入性

注册 (预期的)

360

阶段

  • 第三阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • London、英国、SW17 0RE
        • St. George's Healthcare Trust
    • Surrey
      • Carshalton、Surrey、英国、SM5 1AA
        • St. Helier NHS Trust
      • Croydon、Surrey、英国、CR7 7YE
        • Mayday University Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

16年 及以上 (孩子、成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Stroke or TIA in last 9 months
  • Blood pressure above 140/85 when measured more than 1 week after stroke or on anti hypertensive medication

Exclusion Criteria:

  • Severe illness likely to dominate pattern of care
  • Already using home blood pressure monitor
  • Non-English speaking
  • Severe cognitive impairment (AMTS<7)
  • Known secondary hypertension

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:控制

Patients will not receive a blood pressure monitor and will continue with usual GP care for hypertension management.

GPs will be sent information about the study design, current guidelines and interpretation of home blood pressure readings.

实验性的:Intervention

Patients will be given a home blood pressure monitor and taught how to use it and how to respond to the readings using a standardised protocol and blood pressure targets. The study nurse will follow up patients at home after a month with additional telephone support according to a defined protocol. Patients will consult their own GP for medication changes when above target.

GPs will be sent information about the study design, current guidelines and interpretation of home blood pressure readings.

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Reduction in systolic blood pressure taken by study team at home visit
大体时间:12 months
12 months

次要结果测量

结果测量
大体时间
EQ-5D
大体时间:12个月
12个月
Reduction in diastolic blood pressure taken by study team at home visit
大体时间:12 months
12 months
Reduction in SBP and DBP taken by study team at home visit
大体时间:6 months
6 months
Number of prescribed anti hypertensive medications Number of changes to anti hypertensive medication
大体时间:12 months
12 months
FEAR
大体时间:12 months
12 months
Incremental cost of the intervention to the NHS and cost per QALY
大体时间:12 months
12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Sally Kerry, MSc、St George's, University of London

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2007年3月1日

研究完成 (实际的)

2009年4月1日

研究注册日期

首次提交

2007年8月9日

首先提交符合 QC 标准的

2007年8月9日

首次发布 (估计)

2007年8月10日

研究记录更新

最后更新发布 (估计)

2015年6月9日

上次提交的符合 QC 标准的更新

2015年6月5日

最后验证

2007年8月1日

更多信息

与本研究相关的术语

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅